Propel Bio Partners

About The Fund

Propel Bio Partners is an investment firm dedicated to driving forward advancements in human health through disruptive therapies and technologies. They specialize in the BioTech, HealthTech and Fitness, Medical Devices and Hospital Services, Healthcare and Wellness, Consumer, and Pharmaceutical and Medicine industries. With a clear focus on early-stage companies, Propel Bio Partners invests primarily in Seed, Series A, and Series B funding rounds. Their investments range from a minimum of $100,000 to a maximum of $5,000,000, with a sweet spot of around $1,500,000 per investment. Their approach to investment is centered on building ecosystems that support entrepreneurial life science companies not just financially but also by providing an ecosystem of experts in life science, finance, and investment. This network is designed to help founders navigate the complexities of the industry and advance science purposely and efficiently. By tapping into a rich entrepreneurial ecosystem and leveraging a blend of science and business expertise, Propel Bio Partners aims to help founders fulfill their mission to improve human health with innovative and groundbreaking technologies and therapies. The firm is actively engaging through various channels such as their blog and podcasts, indicating a commitment to thought leadership and staying at the forefront of industry developments. Propel Bio Partners values an entrepreneurial spirit in the sectors they invest in, signifying a strong partnership approach to support the growth and success of the companies in their portfolio.